Clinical Trial Update: Evaluation of A Partially Hydrolyzed in Improving FGIDs Symptoms [NA]

View source ↗

Summary

A clinical trial evaluating a partially hydrolyzed product for functional gastrointestinal disorders has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Gastrointestinal Disorders

Drugs mentioned

• Partially Hydrolyzed Formula (investigational)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Functional Gastrointestinal Disorders | NA | Status: WITHDRAWN